Excess sodium consumption is a major contributor to hypertension and heart disease with a big part of the typical person’s intake hidden in processed foods. With this health crisis front of mind, the WHO has set a target for slashing global sodium consumption by 30% by 2025, which it estimates will save 7 million lives by 2030.
One market minnow on a mission to reduce sodium consumption and heart disease is MicroSalt (SALT:AIM), producer of a patented full-flavour, low-sodium salt for food manufacturers and consumers that is strengthening its intellectual property position and could reward a punt if its technology fulfils its tasty potential over the next decade, though the market newcomer is no stock for widows and orphans.
Read full article here.
